Eiger Biopharmaceuticals Inc (EIGR) Inventory Turnover Ratio, from fourth quarter 2023 to fourth quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Eiger Biopharmaceuticals Inc   (NASDAQ: EIGR)
 

Eiger Biopharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the fourth quarter 2023, Eiger Biopharmaceuticals Inc 's inventory turnover ratio sequentially decreased to 0.19 in the fourth quarter 2023, unsurprisingly, as the Eiger Biopharmaceuticals Inc markets continue to deteriorate, and EIGR's faces growing challenges to bring down its inventories. Eiger Biopharmaceuticals Inc 's average inventory processing period in the Dec 31 2023 quarter, has increased to 1921 days, from 1659 days, in the Sep 30 2023 quarter.

Within Healthcare sector 418 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1340 in the third quarter 2023, to 1536.

EIGR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Eiger Biopharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EIGR Inventory Turnover Ratio (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Inventory Growth -45.46 % -60.77 % -61.82 % 179.48 % 9.23 %
Y / Y Cost of Sales Growth -39.42 % -90.66 % - 7.27 % 231.73 %
Inventory Turnover Ratio (TTM) 0.19 0.22 - 0.53 0.7
EIGR's Total Ranking # 1536 # 1340 # 1605 # 1709 # 1563
Average inventory processing period 1878 1641 - 687 519
Seq. Inventory Growth 40.81 % 0.64 % -79.43 % 87.1 % 1.28 %
Seq. Cost of Sales Growth 81.74 % - - -65.8 % -71.97 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 28
Healthcare Sector # 419
Overall Market # 1536

Inventory Turnover Ratio Statistics
High Average Low
0.7 0.42 0.19
(Dec 31 2022)   (Dec 31 2023)



EIGR Company Profile >> Back to EIGR Efficiency Comparisons >> Compare EIGR Inventory Turnover Ratio to its Competitors

Financial Statements
Eiger Biopharmaceuticals Inc 's Inventories $ 2 Millions Visit EIGR's Balance sheet
Eiger Biopharmaceuticals Inc 's Cost of Revenues TTM $ 0 Millions Visit EIGR's Income Statement
What are EIGR's Sales? Visit EIGR's Sales by Segment

Other Inventory Turnover Ratios
Eiger Biopharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
EIGR's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for EIGR's Competitors
Inventory Turnover Ratio for EIGR's Suppliers
Inventory Turnover Ratio for EIGR's Customers

You may also want to know
EIGR's Sales Growth Rates EIGR's Pe Price to earnings ratio EIGR's Receivables Turnover Ratio EIGR's Stock Quote
EIGR's Net Income Growth Rates EIGR's Ps Price to Sales ratio EIGR's Sales per Employee EIGR's Asset Turnover Ratio
EIGR's Net Margin EIGR's Pb Price to Book ratio EIGR's Financial Strength Ratios EIGR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2023 Inventories at quarter ending Dec 31 2023
Rapid Micro Biosystems Inc   0.78 $ 15.961  Millions$ 21  Millions
Amicus Therapeutics inc   0.76 $ 37.000  Millions$ 49  Millions
Supernus Pharmaceuticals inc   0.75 $ 64.152  Millions$ 86  Millions
Durect Corp  0.75 $ 1.717  Millions$ 2  Millions
Emmaus Life Sciences Inc   0.73 $ 1.342  Millions$ 2  Millions
Cumberland Pharmaceuticals Inc   0.71 $ 6.067  Millions$ 9  Millions
Amarin Corp Plcuk  0.68 $ 141.370  Millions$ 208  Millions
Whitehawk Therapeutics Inc   0.65 $ 2.809  Millions$ 4  Millions
Femasys Inc   0.65 $ 0.380  Millions$ 1  Millions
Bioxcel Therapeutics Inc   0.64 $ 1.260  Millions$ 2  Millions
Vycor Medical Inc   0.61 $ 0.135  Millions$ 0  Millions
Butterfly Network Inc   0.61 $ 49.000  Millions$ 81  Millions
Paragon 28 inc   0.60 $ 51.000  Millions$ 85  Millions
Scpharmaceuticals Inc   0.60 $ 3.811  Millions$ 6  Millions
Nuo Therapeutics Inc   0.59 $ 0.126  Millions$ 0  Millions
Cvrx inc   0.58 $ 6.000  Millions$ 10  Millions
Reflect Scientific Inc  0.53 $ 0.484  Millions$ 1  Millions
Marinus Pharmaceuticals Inc   0.53 $ 1.047  Millions$ 2  Millions
Biomarin Pharmaceutical Inc  0.51 $ 514.854  Millions$ 1,008  Millions
Catheter Precision Inc   0.51 $ 0.030  Millions$ 0  Millions
Macrogenics Inc   0.48 $ 0.619  Millions$ 1  Millions
Blueprint Medicines Corporation  0.47 $ 8.540  Millions$ 18  Millions
Kyntra Bio Inc   0.45 $ 18.848  Millions$ 41  Millions
Arcutis Biotherapeutics Inc   0.43 $ 4.987  Millions$ 12  Millions
Tg Therapeutics Inc   0.43 $ 14.131  Millions$ 33  Millions
Creative Medical Technology Holdings Inc   0.41 $ 0.004  Millions$ 0  Millions
Maxcyte inc   0.41 $ 4.742  Millions$ 12  Millions
Orthopediatrics Corp  0.39 $ 37.000  Millions$ 96  Millions
Regeneron Pharmaceuticals Inc   0.37 $ 932.100  Millions$ 2,519  Millions
Ionis Pharmaceuticals Inc   0.36 $ 9.133  Millions$ 25  Millions

Date modified: 2026-09-08T15:11:13+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.